<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Allen SW</submitter><funding>Centers for Disease Control and Prevention</funding><funding>NIAID NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIH HHS</funding><funding>CDC HHS</funding><pagination>e1031-e1038</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11565896</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>230(5)</volume><pubmed_abstract>There is an increasing global burden from chikungunya virus (CHIKV). Bangladesh reported a major epidemic in 2017, but it was unclear whether there had been prior widespread transmission. We conducted a nationally representative seroprevalence survey in 70 randomly selected communities immediately before the epidemic. We found that 69 of 2938 sampled individuals (2.4%) were seropositive to CHIKV. Seropositivity to dengue virus (adjusted odds ratio, 3.13 [95% confidence interval, 1.86-5.27]), male sex (0.59 [.36-.99]), and community presence of Aedes aegypti mosquitoes (1.80 [1.05-3.0]7) were significantly associated with CHIKV seropositivity. Using a spatial prediction model, we estimated that across the country, 4.99 (95% confidence interval, 4.89-5.08) million people had been previously </pubmed_abstract><journal>The Journal of infectious diseases</journal><pubmed_title>Results of a Nationally Representative Seroprevalence Survey of Chikungunya Virus in Bangladesh.</pubmed_title><pmcid>PMC11565896</pmcid><funding_grant_id>U01 AI151801</funding_grant_id><funding_grant_id>U01AI151801</funding_grant_id><funding_grant_id>R24 AI120942</funding_grant_id><pubmed_authors>Allen SW</pubmed_authors><pubmed_authors>Paul KK</pubmed_authors><pubmed_authors>Rahman MZ</pubmed_authors><pubmed_authors>Alam MS</pubmed_authors><pubmed_authors>Smull T</pubmed_authors><pubmed_authors>Paul R</pubmed_authors><pubmed_authors>Rahman M</pubmed_authors><pubmed_authors>Gurley ES</pubmed_authors><pubmed_authors>Salje H</pubmed_authors><pubmed_authors>Ribeiro Dos Santos G</pubmed_authors><pubmed_authors>Weaver SC</pubmed_authors><pubmed_authors>Al-Amin HM</pubmed_authors><pubmed_authors>Vanhomwegen J</pubmed_authors><pubmed_authors>Lee KH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Results of a Nationally Representative Seroprevalence Survey of Chikungunya Virus in Bangladesh.</name><description>There is an increasing global burden from chikungunya virus (CHIKV). Bangladesh reported a major epidemic in 2017, but it was unclear whether there had been prior widespread transmission. We conducted a nationally representative seroprevalence survey in 70 randomly selected communities immediately before the epidemic. We found that 69 of 2938 sampled individuals (2.4%) were seropositive to CHIKV. Seropositivity to dengue virus (adjusted odds ratio, 3.13 [95% confidence interval, 1.86-5.27]), male sex (0.59 [.36-.99]), and community presence of Aedes aegypti mosquitoes (1.80 [1.05-3.0]7) were significantly associated with CHIKV seropositivity. Using a spatial prediction model, we estimated that across the country, 4.99 (95% confidence interval, 4.89-5.08) million people had been previously </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2026-07-16T22:37:59.048Z</modification><creation>2025-04-05T18:41:27.892Z</creation></dates><accession>S-EPMC11565896</accession><cross_references><pubmed>38942731</pubmed><doi>10.1093/infdis/jiae335</doi></cross_references></HashMap>